Avr Thrombosis OutcoMe Study

Recruiting Observational Study
Aortic Stenosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
750 (estimated)
Sponsor
East and North Hertfordshire NHS Trust · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to utilise novel biomarkers assessing thrombosis and thrombolysis (through a blood test), to identify patients undergoing either surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) who are at risk of thrombosis, and relate this to clinical thrombotic and thromboembolic adverse events and subclinical valve thrombosis, and identify the timeframe…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male and female patients aged 18 years or over. 2. Patients diagnosed with aortic valve disease, undergoing surgical or transcatheter AVR and free of exclusion criteria below. 3. The patient is willing and able to understand the Patient Information Sheet and provide informed …
Contacts

Diana A Gorog, MD,PhD,FRCP

01707247512

d.gorog@imperial.ac.uk

CONTACT

Rahim Kanji, MBBS,MRCP

01438284753

rahim.kanji04@imperial.ac.uk

CONTACT